CPB
39
2
AES
57
2
DRI
58
-5
ALL
57
-3
AAL
48
-2
CNX
38
-3
AN
50
-2
BAX
41
3
CVS
43
2
EBAY
56
2
DUK
55
-2
BWA
55
2
AMT
30
4
AVY
50
3
AVGO
45
3
APD
52
2
CF
36
-2
CCL
82
-4
CA
36
12
CAG
36
2
CPB
39
2
AES
57
2
DRI
58
-5
ALL
57
-3
AAL
48
-2
CNX
38
-3
AN
50
-2
BAX
41
3
CVS
43
2
EBAY
56
2
DUK
55
-2
BWA
55
2
AMT
30
4
AVY
50
3
AVGO
45
3
APD
52
2
CF
36
-2
CCL
82
-4
CA
36
12
CAG
36
2
Financhill
Back

Denali Therapeutics, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
45

DNLI
Denali Therapeutics, Inc.

Last Price:
$16.86
Seasonality Move:
-13.05%
Buy
78

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
45
Denali Therapeutics, Inc. (DNLI) is a Sell

Is Denali Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Denali Therapeutics, Inc. [DNLI] share price is $16.87. The Score for DNLI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DNLI Stock Price Chart

What is Denali Therapeutics, Inc.'s stock price today?

  • The Denali Therapeutics, Inc. share price today is $16.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 44.75 Sell
Chaikin Money Flow: 463892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.96 - 19.22) Sell
Bollinger Bands (100): (14.22 - 17.66) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.95 Sell
20-day SMA: 17.99 Sell
50-day SMA: 17.23 Sell
200-day SMA: 15.06 Buy
8-day EMA: 17.12 Sell
20-day EMA: 17.49 Sell
50-day EMA: 17.11 Sell
200-day EMA: 16.66 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

Denali Therapeutics, Inc. Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.04 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Denali Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):